Skip to main content
SpringerLink
Log in

Multimodal particle size distributions emitted from HFA-134a solution pressurized metered-dose inhalers

  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

The purpose of this research was to investigate the measurement and in vitro delivery implications of multimodal distributions, occurring near or in the respirable range, emitted from pressurized metered-dose inhalers (pMDIs). Particle size distributions of solution pMDIs containing hydrofluoroalkane-134a (HFA-134a) and ethanol were evaluated using 2 complementary particle-sizing methods: laser diffraction (LD) and cascade impaction (CI). Solution pMDIs were formulated from mixtures of HFA-134a (50%–97.5% wt/wt) and ethanol. A range of propellant concentrations was selected for a range of vapor pressures. The fluorescent probe, Rhodamine B, was included for chemical analysis. The complementary nature of LD and CI allowed identification of 2 dominant particle size modes at 1 and 10 μm or greater. Increasing propellant concentrations resulted in increases in the proportion of the size distributions at the 1-μm mode and also reduced the particle size of the larger droplet population. Despite significant spatial differences and time scales of measurement between the particle-sizing techniques, the fine particle fractions obtained from LD and CI were practically identical. This was consistent with LD experiments, which showed that particle sizes did not decrease with increasing measurement distance, and may be explained by the absence of significant evaporation/disintegration of larger droplets. The fine particle fractions (FPFs) emitted from HFA-134a/ethanol solution pMDI can be predicted on the basis of formulation parameters and is independent of measurement technique. These results highlight the importance of presenting particle size distribution data from complementary particle size techniques.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Alexander DJ. Safety of propellants. J Aerosol Med. 1995;8(suppl 1):S 29–34.

    Google Scholar 

  2. Vervaet C, Byron PR. Drug-surfactant-propellant interactions in HFA-formulations. Int J Pharm. 1999;186(1):13–30.

    Article  CAS  Google Scholar 

  3. Blondino FE, Byron PR. Surfactant dissolution and water solubilization in chlorine-free liquified gas propellants. Drug Dev Ind Pharm. 1998;24(10):935–945.

    CAS  Google Scholar 

  4. Smith IJ. The challenge of reformulation. J Aerosol Med. 1995;8(suppl 1):S 19–27.

    Google Scholar 

  5. Warren SJ, Farr SJ. Formulation of solution metered dose inhalers and comparison with aerosols emitted from conventional suspension systems. Int J Pharm. 1995;124:195–203.

    Article  CAS  Google Scholar 

  6. Seale JP, Harrison LI. Effect of changing the fine particle mass of inhaled beclomethasone dipropionate on intrapulmonary deposition and pharmacokinetics. Respir Med. 1998;92(suppl A):9–15.

    Article  Google Scholar 

  7. Leach C. Effect of formulation parameters on hydrofluoroalkane-beclomethasone dipropionate drug deposition in humans. J Allergy Clin Immunol. 1999;104(6):S 250–252.

    Article  Google Scholar 

  8. Leach CL, Davidson PJ, Hasselquist BE, Boudreau RJ. Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone: a cross-over study in healthy volunteers. Chest. 2002;122(2):510–516.

    Article  CAS  Google Scholar 

  9. Dunbar CA, Watkins AP, Miller JF. An experimental investigation of the spray issued from a pMDI using laser diagnostic techniques. J Aerosol Med. 1997;10(4):351–368.

    Article  CAS  Google Scholar 

  10. Cheng YS, Fu CS, Yazzie D, Zhou Y. Respiratory deposition patterns of salbutamol pMDI with CFC and HFA-134a formulations in a human airway replica. J Aerosol Med. 2001;14(2):255–266.

    Article  CAS  Google Scholar 

  11. Polli GP, Grim WM, Bacher FA, Yunker MH. Influence of formulation on aerosol particle size. J Pharm Sci. 1969;58:484–486.

    Article  CAS  Google Scholar 

  12. Williams RO, Liu J. Influence of formulation additives on the vapor pressure of hydrofluoroalkane propellants. Int J Pharm. 1998;166:99–103.

    Article  CAS  Google Scholar 

  13. Tzou T-Z. Density, excess molar volume, and vapor pressure of propellant mixtures in metered-dose inhalers: deviation from ideal mixtures. In: Dalby RN, Byron PR, Farr SJ, eds. Respiratory Drug Delivery VI. Buffalo Grove, IL: Interpharm Press, Inc; 1998:439–443.

    Google Scholar 

  14. Martin A. Physical Pharmacy. 4th ed. Philadephia, PA: Lippincott Williams & Wilkins; 1993.

    Google Scholar 

  15. Smyth HDC, Hickey AJ. Comparative particle size analysis of solution propellant driven metered dose inhalers using cascade impaction and laser diffraction. In: Dalby RN, Byron PR, Farr SJ, Peart J, eds. Respiratory Drug Delivery VIII. Raleigh, NC: DHI Publishing; 2002:731–734.

    Google Scholar 

  16. United States Pharmacopeia. USP24/NF19. General chapter <601> Aerosols. In: United States Pharmacopeia. Rockville, MD: United States Pharmacopeia; 1999: 1895.

    Google Scholar 

  17. Ranucci J. Dynamic plume-particle size analysis using laser diffraction. Pharm Tech. 1992;16:108, 110, 112, 114.

    Google Scholar 

  18. Newman SP. Use of gamma scintigraphy to evaluate the performance of new inhalers. J Aerosol Med. 1999; 12(suppl 1):S25–31.

    Google Scholar 

  19. Clark AR. Metered Atomization for Respiratory Drug Delivery [dissertation]. Leicestershire, UK: Loughborough University of Technology; 1991.

    Google Scholar 

  20. Dunbar CA, Watkins AP, Miller JF. Theoretical investigation of the spray from a pressurized metered-dose inhaler. Atomization Sprays. 1997;7(4):417–436.

    CAS  Google Scholar 

  21. Finlay WH. The Mechanics of Inhaled Pharmaceutical Aerosols. London, UK: Academic Press; 2001.

    Google Scholar 

  22. Holzner PM, Mueller BW. Particle size determination of metered-dose inhalers by laser diffraction, cascade impaction and liquid impingement. Paper Presented at 1st World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Budapest, 1995: 765–766.

  23. de Boer AH, Gjaltema D, Hagedoorn P, Frijlink HW. Characterization of inhalation aerosols: a critical evaluation of cascade impactor analysis and laser diffraction technique. Int J Pharm. 2002;249(1–2):219–231.

    Article  Google Scholar 

  24. Everard ML. CFC transition: the emperors new clothes. Each class of drug deserves a delivery system that meets its own requirements. Thorax. 2000;55:811–814.

    Article  CAS  Google Scholar 

  25. Leach C. Enhanced drug delivery through reformulating MDIs with HFA propellants: drug deposition and its effect on preclinical and clinical programs. In: Dalby RN, Byron PR, Farr SJ, eds. Respiratory Drug Delivery V. Buffalo Grove, IL: Interpharm Press, Inc; 1996:133–144.

    Google Scholar 

  26. Leach CL, Davidson PJ, Boudreau RJ. Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone. Eur Respir J. 1998;12(6):1346–1353.

    Article  CAS  Google Scholar 

  27. Lefebvre AH. Atomization and Sprays. London, UK: Taylor & Francis; 1989.

    Google Scholar 

  28. Faeth GM, Hsiang LP, Wu PK. Structure and breakup properties of sprays. Int J Multiphase Flow. 1995;21 (suppl): 99–127.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Pharmacy, University of North Carolina at Chapel Hill, 1311 Kerr Hall, CB 7360, 27599, Chapel Hill, NC

    Hugh D. C. Smyth

Authors
  1. Hugh D. C. Smyth
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hugh D. C. Smyth.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smyth, H.D.C. Multimodal particle size distributions emitted from HFA-134a solution pressurized metered-dose inhalers. AAPS PharmSciTech 4, 38 (2003). https://doi.org/10.1208/pt040338

Download citation

  • Received:

  • Accepted:

  • DOI: https://doi.org/10.1208/pt040338

Keywords

Search

Navigation